Massive data review aims to improve HIV care in africa

NCT ID NCT04158895

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will analyze medical records from up to 1 million people in Malawi to understand how different models of HIV treatment delivery are working. The goal is to see which approaches are most effective and efficient, without directly interacting with patients. Findings could help shape better HIV care across Africa.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help identify the most effective and efficient ways to deliver HIV treatment in high-prevalence countries, improving patient outcomes and resource allocation.

What could go wrong

This is an observational study analyzing existing data, so it cannot prove cause and effect. Results may be limited by data quality and may not apply to all settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • All clinics

    RECRUITING

    Lilongwe, Malawi

    Contact Phone: •••-•••-•••• Email: •••••@•••••